Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation

被引：26
|
作者：
Morikawa, Mamoru [1 ]
Yamada, Takashi [1 ]
Yamada, Hideto [1 ]
Minakami, Hisanori [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608638, Japan
来源：
OBSTETRICS AND GYNECOLOGY | 2006年 / 108卷 / 03期
关键词：
D O I：
10.1097/01.AOG.0000191584.28717.2c
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
BACKGROUND: The effect of gonadotropin-releasing hormone agonist (GnRHa) on uterine arteriovenous malformations (AVM) is not well known. CASE: A 37-year-old woman with a previous cesarean was diagnosed as having a uterine AVM after a spontaneous abortion with massive vaginal bleeding. The AVM decreased in size from 5.1 x 3.8 cm to 1.4 x 1.0 cm after 6 months of therapy with a GnRHa. Uterine artery embolization conducted after the GnRH therapy resulted in complete disappearance of the AVM. The patient's menstrual cycles and ovulation resumed 3 months after uterine artery embolization. CONCLUSION: Gonadotropin-releasing hormone agonist therapy reduced the size of the uterine AVM. Thus, GnRHa therapy may be useful for uterine AVM in situations where uterine artery embolization must be postponed.
引用
收藏
页码：751 / 753
页数：3
相关论文
共 50 条
  • [1] Management of Uterine Arteriovenous Malformation: Uterine Artery Embolization followed by Gonadotropin-Releasing Hormone Agonist
    Li, He
    Yi, Xiaofang
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2021, 28 (05) : 936 - 937
  • [2] Resolution of Uterine Arteriovenous Malformation and Successful Pregnancy After Treatment With a Gonadotropin-Releasing Hormone Agonist
    Nonaka, Taro
    Yahata, Tetsuro
    Kashima, Katsunori
    Tanaka, Kenichi
    OBSTETRICS AND GYNECOLOGY, 2011, 117 (02): : 452 - 455
  • [3] Conservative therapy with a gonadotropin-releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease
    Katano, Kinue
    Takeda, Yutaka
    Sugiura-Ogasawara, Mayumi
    CLINICAL CASE REPORTS, 2015, 3 (06): : 479 - 482
  • [4] The effect of extended gonadotropin-releasing hormone agonist administration on uterine leiomyoma histopathology
    Mukherjee, T
    Abadi, M
    Copperman, AB
    Lapinski, R
    Tsai, T
    Jones, J
    Levgur, M
    JOURNAL OF GYNECOLOGIC SURGERY, 1996, 12 (04) : 251 - 255
  • [5] Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma
    Abulafia, O
    Kleinhaus, K
    Levi, G
    Lee, YC
    Sherer, DM
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2001, 52 (02) : 108 - 113
  • [6] TREATMENT OF UTERINE FIBROIDS WITH AGONIST ANALOGS OF GONADOTROPIN-RELEASING HORMONE
    KESSEL, B
    LIU, J
    MORTOLA, J
    BERGA, S
    YEN, SSC
    FERTILITY AND STERILITY, 1988, 49 (03) : 538 - 541
  • [7] GONADOTROPIN-RELEASING HORMONE AGONIST AS AN ADJUNCT IN CONSERVATIVE SURGERY FOR UTERINE LEIOMYOMAS
    TANBO, T
    ABYHOLM, T
    SKJAERAASEN, J
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1989, 68 (03) : 265 - 266
  • [8] Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma
    Higashijima, T
    Kataoka, A
    Nishida, T
    Yakushiji, M
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 68 (1-2): : 169 - 173
  • [9] Negative regulation of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor gene expression by a gonadotropin-releasing hormone agonist in the rat hypothalamus
    Han, YG
    Kang, SS
    Seong, JY
    Geum, D
    Suh, YH
    Kim, K
    JOURNAL OF NEUROENDOCRINOLOGY, 1999, 11 (03) : 195 - 201
  • [10] TREATMENT OF UTERINE FIBROIDS WITH IMPLANTS OF GONADOTROPIN-RELEASING HORMONE AGONIST - ASSESSMENT BY HYSTEROGRAPHY
    DONNEZ, J
    SANDOW, J
    SCHRURS, B
    CLERCKX, F
    GILLEROT, S
    FERTILITY AND STERILITY, 1989, 51 (06) : 947 - 950
12345